Katherine Weilbaecher
7PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 21, 2025
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer.Foluso O Ademuyiwa, Cynthia X Ma, Katherine Weilbaecher
|Apr 04, 2024
Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME.Tri Giang Phan, Katherine N Weilbaecher, Rebecca Aft
|Dec 20, 2023
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting.Francesca Fontana, Alison K Esser, Christopher Egbulefu
|Mar 08, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy.Douglas V Faget, Xianmin Luo, Matthew J Inkman
|Jan 24, 2023
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.Andrew A Davis, Jingqin Luo, Tiantian Zheng
|Sep 23, 2021
Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors.Jingyu Xiang, Min Shi, Mark A Fiala
Pageof 2
Frequent Collaborators
2 joint publications
Caron Rigden
2 joint publications
Lindsay L Peterson
2 joint publications
Katherine Clifton
2 joint publications
Foluso O Ademuyiwa
2 joint publications
Cynthia X Ma
2 joint publications
Ashley Frith
2 joint publications
Rama Suresh
2 joint publications
Andrew Davis
1 joint publications
Samuel Achilefu
1 joint publications
Mark A Schroeder
